Obesity in heart failure with preserved ejection fraction: Insights from the REDUCE LAP-HF II trial

- Litwin, Sheldon E., Komtebedde, Jan, Hummel, Scott L., Bugger, Heiko, Boenner, Florian, Hoendermis, Elke, Cikes, Maja, Demers, Catherine, Silva, Guillherme, van Empel, Vanessa, Starling, Randall C., Penicka, Martin, Seidler, Tim, Cutlip, Donald E., Leon, MB, Kitzman, DW, van Veldhuisen, DJ, Shah, SJ, REDUCE LAP-HF investigators and research staff,, Borlaug, Barry A., Winkler, Sebastian, Solomon, Scott D., Eicher, Jean-Christophe, Mazimba, Sula, Khawash, Rami, Sverdlov, Aaron L.

Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial

- Shah, Sanjiv J., Borlaug, Barry A., Litwin, Sheldon E., Lurz, Philipp, Massaro, Joseph M., Mohan, Rajeev C., Ricciardi, Mark J., Solomon, Scott D., Sverdlov, Aaron L., Swarup, Vijendra, van Veldhuisen, Dirk J., Winkler, Sebastian, Chung, Eugene S., Leon, Martin B., REDUCE LAP-HF II investigators,, Cutlip, Donald E., Debonnaire, Philippe, Fail, Peter S., Gao, Qi, Hasenfuß, Gerd, Kahwash, Rami, Kaye, David M.